Premium
Inhibitors of Endocannabinoid Degradation: Potential Therapeutics for Neurological Disorders
Author(s) -
Wendeler Michaela,
Kolter Thomas
Publication year - 2003
Publication title -
angewandte chemie international edition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.831
H-Index - 550
eISSN - 1521-3773
pISSN - 1433-7851
DOI - 10.1002/anie.200301641
Subject(s) - endocannabinoid system , 2 arachidonoylglycerol , anxiolytic , pharmacology , degradation (telecommunications) , analgesic , neuroscience , medicine , chemistry , biology , cannabinoid receptor , anxiety , psychiatry , computer science , antagonist , receptor , telecommunications
Joint benefits: Selective inhibitors of endocannabinoid degradation have been developed, among them the shown carbamate, which exhibit anxiolytic and analgesic properties in laboratory animals.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom